| Overview |
| bsm-61101r-pe-cy3-100ul |
| Caveolin-2 Recombinant Monoclonal Antibody, PE-Cy3 Conjugated |
| WB |
| Human |
| Specifications |
| PE-Cy3 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Caveolin 2 |
| Monoclonal |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 858 |
| P51636 |
| Cytoplasm, Nucleus, Cell membrane |
| CAV2; Caveolae protein 20 Kd; Caveolin 2; Caveolin 2 isoform a and b; Caveolin-2. |
| May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. Acts as an accessory protein in conjunction with CAV1 in targeting to lipid rafts and driving caveolae formation. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz